CytomX Therapeutics Lands $31,000,000 Series B Financing
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=a920a449-be51-4417-bc94-461c8074e237&Preview=1 -
Date
7/31/2012 -
Company Name
CytomX Therapeutics -
Mailing Address
650 Gateway Blvd South San Francisco, CA 94080 -
Company Description
CytomX Therapeutics is an early stage, privately-funded biotechnology company developing Probodies, proteolytically-activated antibodies. -
Website
http://www.cytomx.com -
Transaction Type
Venture Equity -
Transaction Amount
$31,000,000 -
Transaction Round
Series B -
Proceeds Purposes
Proceeds from the expanded Series B financing round will support the advancement of the company’s lead programs toward the clinic and the execution on broad business development activities aimed at the formation of key partnerships in oncology and inflammatory disease. -
M&A Terms
-
Venture Investor
Canaan Partners -
Venture Investor
Third Rock Ventures -
Venture Investor
Roche Venture Fund
